Skip to main content
    C

    CNS Pharmaceuticals Inc (CNSP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.07
    -0.28 (-5.23%)

    Market Cap: $7.82M

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(16/24)
    Avg Surprise
    -53.55%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.27
    Range$-0.27 - $-0.27
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$-0.74+63.5%
    30d ago$-0.74+63.5%
    7d ago$-0.74+63.5%
    Current$-0.27
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$4.23
    Range$4.23 - $4.23
    1 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$4.23---
    Sep 26EST
    		-$-0.27---
    Jun 26
    Reported Aug 12
    		$-0.38$-0.24-58.33%Miss+94.1%
    Mar 26
    Reported May 14
    		$-7.30$-5.37-35.94%Miss-362.0%
    Dec 25
    Reported Mar 31
    		$-10.15$-5.09-99.41%Miss+72.8%
    Sep 25
    Reported Nov 14
    		$-5.76$-6.63+13.12%Beat+96.2%
    Jun 25
    Reported Aug 14
    		$-6.42$-9.60+33.13%Beat+4.5%
    Mar 25
    Reported May 15
    		$-1.58$-2.00+21.00%Beat-288.4%
    Dec 24
    Reported Mar 31
    		$-37.33$-7.33-409.28%Miss+99.9%
    Sep 24
    Reported Nov 14
    		$-150.00$-60.00-150.00%Miss+99.5%
    Jun 24
    Reported Aug 14
    		$-6.72$0.00N/ABeat+100.0%
    Mar 24
    Reported Apr 1
    		$-0.41$0.00N/ABeat+84.3%
    Dec 23
    Reported Mar 14
    		$-28622.96$0.00N/ABeat-748976.5%
    Sep 23
    Reported Nov 14
    		$-32400.01$-51900.02+37.57%Beat+60.0%
    Jun 23
    Reported Aug 14
    		$-31200.01N/A+63.12%Beat+61.5%
    Mar 23
    Reported May 15
    		$-2.59$0.00N/ABeat+100.0%
    Dec 22
    Reported Mar 31
    		$-3.82$-2.40-59.21%Miss-27.4%
    Sep 22
    Reported Nov 10
    		$-81000.11$-90000.13+10.00%Beat+35.7%
    Jun 22
    Reported Aug 12
    		$-81000.11$-72000.10-12.50%Miss+40.0%
    Mar 22
    Reported May 16
    		$-63000.09$-126000.18+50.00%Beat+53.3%
    Dec 21
    Reported Mar 3
    		$-3.00$-4.80+37.50%Beat+100.0%
    Sep 21
    Reported Nov 12
    		$-126000.18$-132000.18+4.55%Beat-16.7%
    Jun 21
    Reported Aug 13
    		$-135000.19$-117000.16-15.38%Beat+0.0%
    Mar 21
    Reported May 14
    		$-135000.19$-108000.15-25.00%Beat-25.0%
    Dec 20
    Reported Feb 12
    		$-162000.23$-105750.15-53.19%Beat-3176375.1%
    Sep 20
    Reported Nov 12
    		$-108000.15$-112500.16+4.00%Beat-140.0%
    Jun 20
    Reported Aug 10
    		$-135000.19$-72000.10-87.50%Beat-450000533.3%
    Mar 20
    Reported May 15
    		$-108000.15$-90000.13-20.00%Beat-22978655.3%
    Dec 19
    Reported Mar 12
    		$-5.10$-0.90-466.67%Miss-
    Sep 19
    Reported Dec 20
    		$-45000.06$-27000.04-66.67%Beat-
    Jun 19
    Reported Aug 28
    		$-0.03$0.00N/AMiss-
    Mar 19
    Reported Jun 28
    		$-0.47$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.21EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-106.60%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage-1116.16x
    Current Ratio5.86xQuick Ratio5.86x
    Trading Statistics
    Beta1.02Avg Volume3.68K
    52-Week High$10.5452-Week Low$1.90

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.30
    SMA 20$5.22
    SMA 50$5.47
    SMA 200$4.63
    EMA 10$5.26
    EMA 20$5.30
    EMA 50$5.33
    EMA 200$5.53

    MACD

    Line: -0.05Signal: -0.06Hist: 0.01

    ADX

    ADX: 16.4+DI: 16.5-DI: 35.6

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down52.0
    PSAR$5.00

    Bollinger Bands

    Upper Band$5.50
    Lower Band$4.94
    %B Position1086%(Upper)
    Band Width0.24

    RSI (14-Day)

    Neutral
    42.4

    Momentum Oscillators

    Stoch %K58.9
    Stoch %D63.4
    Williams %R-72.5
    ROC (10d)-3.2%
    Momentum-0.17
    CCI (20d)-69.4
    MFI (14d)69.9

    Volatility Measures

    ATR (14d)$0.23(4.6%)
    StdDev (20d)0.14
    Hist Vol48.4%(High)

    Volume Flow

    VWAP$5.10
    OBV167.6M
    AD Line5.3B
    CMF (20d)0.202

    Volume Metrics

    Avg Vol (20d)3.7K
    Vol Ratio0.2x(Low)
    VWMA (20d)$5.27

    Pivot Points

    R3$5.35
    R2$5.35
    R1$5.35
    Pivot Point$5.35
    S1$5.35
    S2$5.35
    S3$5.35

    Advanced Oscillators

    TSI-5.90
    Ultimate Osc54.3
    KST-52.37

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$3,140$0$0$0$0$0
    Cost of Revenue$0$0$-2,898$0$0$0$985$0$0$0N/A$0
    Gross Profit$0$0$2,898$0$0$0$-985$0$0$0N/A$0
    Operating Expenses$2.70M$4.98M$5.99M$3.25M$2.41M$4.34M$3.20M$5.63M$2.53M$3.54M$5.38M$4.53M
    R&D$1.20M$3.54M$3.17M$2.20M$1.17M$3.24M$1.50M$4.24M$1.12M$2.43M$4.27M$3.41M
    SG&A$1.50M$1.43M$2.82M$1.06M$1.24M$1.09M$1.70M$1.38M$1.41M$1.11M$1.11M$1.12M
    Operating Income$-2,700,000$-4,975,205$-5,986,126$-3,253,388$-2,409,000$-4,337,660$-3,200,048$-5,628,906$-2,528,135$-3,544,854$-5,379,371$-4,533,840
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$4,000$6,111$2,721$2,116$4,000$6,208$2,774$2,258$4,463$6,625$2,881$1,838
    Income Before Tax$-2,588,000$-4,937,046$-5,955,802$-3,218,481$-2,375,000$-4,301,320$-3,176,366$-5,605,934$-2,530,753$-3,544,748$-5,375,250$-4,522,795
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-2,588,000$-4,937,046$-5,955,802$-3,218,481$-2,375,000$-4,301,320$-3,176,366$-5,605,934$-2,530,753$-3,544,748$-5,375,250$-4,522,795
    EBITDA$-2,572,868$-4,929,067$-5,952,061$-3,215,668$-2,370,100$-4,294,012$-3,172,607$-5,602,925$-2,525,538$-3,537,305$-5,378,418$-4,520,058
    EBIT$-2,584,000$-4,930,935$-5,953,081$-3,216,365$-2,371,000$-4,295,112$-3,173,592$-5,603,676$-2,526,290$-3,538,123$-5,379,371$-4,520,957
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CNSP

    News

    CNS Pharmaceuticals Share Price - CNSP, RNS News, Articles, Quotes, & Charts (NASDAQ:CNSP)

    CNS Pharmaceuticals (NASDAQ:CNSP) is a biotechnology company focused on developing treatments for brain and central nervous system tumors. Its lead candidate, Berubicin, is being developed for glioblastoma...

    Proactive financial news•10/8/26•Somewhat-Bullish

    CNSP: Cns Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas

    This article provides the latest stock price, analysis, news, and trading ideas for CNS Pharmaceuticals Inc (CNSP). It details the company's financial metrics...

    Stocktwits•10/2/26•Somewhat-Bullish

    With 45.72% of shares represented, CNS Pharmaceuticals (CNSP) wins approval to expand its stock plan.

    CNS Pharmaceuticals (CNSP) stockholders approved an amendment to its 2020 Equity Plan, adding 650,000 shares for a total of 765,061 authorized shares. The vote occurred at the September 30, 2026 annual meeting...

    Stock Titan•10/2/26•Neutral

    Vertical Data: Downs Most Recently Served as CFO of CNS Pharmaceuticals >VDTA

    This article from Vertical Data states that the company's new CFO, John Downs, most recently held the CFO position at CNS Pharmaceuticals. The article is very short, providing only this piece of information.

    Moomoo•8/19/26•Neutral

    CNS Pharmaceuticals director Michal Fisher buys $10,000 in stock By Investing.com

    Michal Fisher, a director at CNS Pharmaceuticals, Inc. (NASDAQ:CNSP), recently purchased 2,000 shares of the company's common stock for $10,000. This transaction occurred on May 18, 2026, at a price of $5.00 per share...

    Investing.com South Africa•8/19/26•Bullish

    CNSP Valuation and Fair Value

    P/E
    -0.2x
    P/B
    1.9x
    See GNG's fair value

    CNSP Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -106.6%

    CNSP Competitors

    CompanyTicker
    OSR Holdings IncOSRH
    Collplant Biotechnologies LtdCLGN
    Exicure IncXCUR
    Tenon Medical IncTNON
    Jaguar Animal Health IncJAGX
    Senti Biosciences IncSNTI
    Hoth Therapeutics IncHOTH
    Aprea Therapeutics IncAPRE

    Sector: Healthcare

    CNSP Bull Case vs Bear Case

    Bear case

    • CNSP beat EPS estimates in 37.5% of its last 8 reported quarters.

    CNSP Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -85.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.27
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About CNSP

    Does CNSP pay dividends?

    CNS Pharmaceuticals Inc (CNSP) does not currently pay a regular dividend.

    What is CNSP's market cap?

    CNS Pharmaceuticals Inc (CNSP) has a market capitalization of $7.82M with a current stock price of $5.07.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In